Abstract Between 30% and 70% of patients with breast cancer have pre-existing chronic
conditions, and more than half are on long-term non-cancer medication at the time of …

Background Elderly breast cancer (BC) patients have been underrepresented in clinical
trials whereas~ 60% of deaths from BC occur in women aged 70 years and older. Only …

Highlights•Older population represents∼ 50%-60% of newly diagnosed cancer
patients.•This population is at higher risk of anticancer drug toxicity due to comorbidities and …

Objective: Multicomponent bandages (MCBs) are recommended by the French Authority for
Health (Haute Autorité de Santé) as first-line treatment for venous leg ulcers (VLUs). A first …

Objective: To evaluate the healing outcomes and costs associated with the aetiological
management of venous leg ulcers (VLUs) treated with recommended multicomponent …

Introduction Chemotherapy (CT) is commonly used as an adjuvant treatment for women with
early breast cancer (BC). However, not all patients benefit from CT, while all are exposed to …

Women diagnosed with early-stage breast cancer can develop metastatic disease following
successful initial treatment, with bone being the most common site of metastases. The Breast …

Cancer is the second leading cause of mortality in EU countries, and the needs to tackle
cancer are obvious. New scientific understanding, techniques and methodologies are …

Simple Summary Improved outcomes have been reported with adjuvant treatment
combining cyclin-dependent kinase 4/6 inhibitors with endocrine therapy, in high-risk …

Background Genitourinary syndrome of menopause (GSM) frequently occurs after breast
cancer (BC), leading to symptoms that can severely affect quality of life. Vaginal estrogen …